IRIS
MONTECUCCO, CARLOMAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.667
AS - Asia 15.142
EU - Europa 12.665
SA - Sud America 1.980
AF - Africa 230
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 49.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.272
CN - Cina 8.497
SG - Singapore 3.349
IE - Irlanda 3.252
HK - Hong Kong 1.784
UA - Ucraina 1.698
DE - Germania 1.662
BR - Brasile 1.636
RU - Federazione Russa 1.553
FI - Finlandia 1.474
SE - Svezia 863
IT - Italia 766
GB - Regno Unito 602
VN - Vietnam 546
CA - Canada 246
IN - India 224
FR - Francia 207
AR - Argentina 137
JP - Giappone 119
AT - Austria 104
BD - Bangladesh 104
MX - Messico 85
PL - Polonia 82
ZA - Sudafrica 77
TR - Turchia 75
IQ - Iraq 72
ES - Italia 67
BE - Belgio 66
EC - Ecuador 63
NL - Olanda 63
CZ - Repubblica Ceca 48
ID - Indonesia 43
IR - Iran 41
CO - Colombia 39
AE - Emirati Arabi Uniti 34
LT - Lituania 31
MA - Marocco 31
SA - Arabia Saudita 30
PK - Pakistan 29
VE - Venezuela 25
CL - Cile 24
IL - Israele 21
EG - Egitto 20
KE - Kenya 20
AU - Australia 19
PY - Paraguay 19
UZ - Uzbekistan 19
PE - Perù 18
DO - Repubblica Dominicana 17
MU - Mauritius 16
RO - Romania 16
TN - Tunisia 16
NP - Nepal 15
AZ - Azerbaigian 14
JO - Giordania 14
KZ - Kazakistan 14
LV - Lettonia 13
AL - Albania 12
PH - Filippine 12
UY - Uruguay 12
DZ - Algeria 11
DK - Danimarca 10
EU - Europa 10
KR - Corea 10
CR - Costa Rica 9
HU - Ungheria 9
KG - Kirghizistan 9
SN - Senegal 9
BG - Bulgaria 8
BY - Bielorussia 7
CH - Svizzera 7
LK - Sri Lanka 7
TH - Thailandia 7
ET - Etiopia 6
GE - Georgia 6
GR - Grecia 6
MK - Macedonia 6
OM - Oman 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
JM - Giamaica 5
LB - Libano 5
NI - Nicaragua 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
PT - Portogallo 4
BW - Botswana 3
CG - Congo 3
EE - Estonia 3
GD - Grenada 3
MD - Moldavia 3
Totale 49.666
Salva come PNG Salva come JPEG
Città #
Dublin 3.232
Chandler 3.007
Jacksonville 2.265
Nanjing 1.840
Hong Kong 1.777
Dallas 1.638
Ashburn 1.626
Singapore 1.387
Beijing 1.264
Boardman 986
Nanchang 757
Princeton 720
Lawrence 662
Wilmington 620
Helsinki 584
Shenyang 553
Changsha 551
Hebei 539
Los Angeles 504
Medford 471
Munich 435
Jiaxing 426
New York 364
Hangzhou 317
Tianjin 308
Redondo Beach 282
Shanghai 280
Ann Arbor 276
Moscow 276
Buffalo 249
Milan 202
Ho Chi Minh City 189
São Paulo 152
Houston 146
Woodbridge 145
Turku 144
Pavia 142
Norwalk 132
Hanoi 120
Tokyo 103
Seattle 101
Verona 100
Chicago 92
Toronto 92
Brooklyn 84
Fairfield 80
Falkenstein 78
Warsaw 77
Vienna 74
The Dalles 72
Guangzhou 70
Brussels 66
Montreal 63
Santa Clara 63
London 62
San Francisco 58
Zhengzhou 58
Jinan 56
Stockholm 56
Denver 55
Chennai 54
Orem 54
Rio de Janeiro 54
Washington 51
Boston 48
Ningbo 48
Johannesburg 47
Nuremberg 46
Atlanta 45
Belo Horizonte 44
Poplar 43
Columbus 42
Pune 41
Phoenix 40
Frankfurt am Main 37
Kunming 33
Ankara 32
Manchester 32
Mexico City 32
Porto Alegre 32
Des Moines 31
Brasília 30
Brno 29
Council Bluffs 28
Piscataway 28
San Jose 26
Quito 25
Curitiba 24
Taizhou 24
Redwood City 23
Secaucus 23
Changchun 22
Fuzhou 22
Rome 22
Haiphong 21
Lanzhou 21
Amsterdam 20
Borås 20
Campinas 20
Dubai 20
Totale 32.462
Salva come PNG Salva come JPEG
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 244
Ultrasonographic evaluation of entheses in patients with spondyloarthritis: a systematic literature review 182
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 160
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 135
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 131
Milwaukee shoulder syndrome(artropatia destruente apatite-associata):aspetti terapeutici 130
[Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis.] 128
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 127
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 124
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 124
[Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)]. 123
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 123
B cells in rheumatoid arthritis. 122
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 120
DMARDS and infections in rheumatoid arthritis 119
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 119
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 118
Antinuclear antibodies in systemic sclerosis 117
A case of adult onset Still's disease treated with infliximab - Reply 115
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 113
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 112
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 112
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 111
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 111
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 110
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 110
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 110
Shrinking lung syndrome in sistemic sclerosis 110
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 109
Analysis of Human Myeloma Cell-population Kinetics 109
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 109
Clinical, genetic amd immunologic analysis of a family affected by Ozena. 108
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. 108
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 108
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 108
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 108
Localized and systemic forms of scleroderma in adults and children. 107
Interessamento cutaneo nella dermatomiosite 107
Chemochine linfoidi nella sinovite reumatoide 107
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 107
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 107
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 107
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 107
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 106
B cells in rheumatoid arthritis. 106
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 106
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 106
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 105
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 105
[Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy]. 105
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 105
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 105
Disease-related malnutrition in systemic sclerosis: Evidences and implications 105
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 104
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 104
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 104
Diffuse skin reaction after changing the etanercept formulation 103
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 103
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 103
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 103
A genetic variation located in the promoter region of the UPAR(CD87) gene is associated with the vascular complications of systemic sclerosis. 102
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 102
Multidisciplinary model for hospital-territory integrated management of patient with bone fragility: Primary and secondary prevention of fractures according to severity and complexity 102
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 101
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 101
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 101
Influenza may influence rheumatoid arthritis 100
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 100
Association between anti-dsDNA titre increase and thymoma relapse 99
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 99
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 99
A Flow Cytometric Study of the Propidium Iodide Staining Kinetics of Human-leukocytes and Its Relationship With Chromatin Structure 99
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 98
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 98
B cell autoimmunity and bone damage in rheumatoid arthritis 98
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 98
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 98
Clinical, genetic and immunologic analysis of a family affected by ozena 97
null 97
G2 synchronization in human acute leukemia after VP 16 213 therapy. 97
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 97
Clinical and experimental evidences of Italian viper venom neurotoxicity. 96
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 96
[Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine] 96
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 96
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 95
Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis 94
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 94
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 94
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 93
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 93
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 93
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 93
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 93
[Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis] 93
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 92
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica 92
Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease 92
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 92
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 92
Totale 10.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.333 0 0 0 0 0 458 40 559 158 525 443 150
2021/20222.729 49 18 71 28 60 93 58 178 148 60 441 1.525
2022/20239.143 1.111 618 87 609 945 914 8 506 3.841 61 241 202
2023/20243.418 408 732 131 238 309 858 105 221 36 119 101 160
2024/20259.508 230 786 167 251 116 460 491 746 2.327 356 1.048 2.530
2025/202611.297 1.636 1.591 2.559 2.172 2.456 883 0 0 0 0 0 0
Totale 50.881